<DOC>
	<DOC>NCT01651481</DOC>
	<brief_summary>The purpose of this study is to evaluate the pharmacokinetics and safety of Singulair (10 mg) and Xyzal (5 mg) in free combination and fixed-dose combination as HCP1102</brief_summary>
	<brief_title>Study to Evaluate the Pharmacokinetics and Safety of Singulair and Xyzal in Free Combination and Fixed-dose Combination</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Levocetirizine</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Healthy male Age between 20 and 55 Signed informed consent Has a history of hypersensitivity to IP ingredients Hypotension or hypertension Has a history of acute infection within 14 days of screening</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Rhinitis</keyword>
</DOC>